Galidesivir Market

Galidesivir is an adenosine analogue that has been investigated for use against Zaire Ebolavirus. In animal studies, galidesivir was effective in increasing the survival rates from infections caused by various pathogens, including Ebola, Marburg, Yellow Fever and Zika viruses. Phase 1 clinical trials have begun to determine the safety of this drug in humans. Because of its activity against other coronaviruses, it may be studied as a potential therapy for COVID-19.

Galidesivir Market contains market size and forecasts of Galidesivir in Global, including the following market information:

• Global Galidesivir Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Galidesivir market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Galidesivir Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Galidesivir include BioCryst Pharmaceuticals, ChemScene, Taiclone, CliniSciences, Xi'an Henrikang Biotech Co. and Cayman Chemical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Galidesivir companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Galidesivir Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Galidesivir Market Segment Percentages, by Type, 2021 (%)

• Galidesivir Powder
• Galidesivir Hydrochloride

Global Galidesivir Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Galidesivir Market Segment Percentages, by Application, 2021 (%)

• Marburg Virus Disease
• Filovirus Infections/Ebola Virus Infection
• Yellow Fever

Global Galidesivir Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Galidesivir Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Galidesivir revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Galidesivir revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• BioCryst Pharmaceuticals
• ChemScene
• Taiclone
• CliniSciences
• Xi'an Henrikang Biotech Co.
• Cayman Chemical